Walleye Trading’s Outset Medical OM Stock Holding History

Walleye Trading’s Portfolio OM Stock Details OM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-1,115	Closed	-$249K	–	5380
2022 Q2	$249K	Buy	+1,115	New	+$480K	﹤0.01%	3532

Other funds holding OM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

EHI

Eagle Health Investments Greenwich, Connecticut $572M AUM 67.49% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Walleye Trading's OM Position: Q3 2022 in Review

Walleye Trading sold out of Outset Medical (OM) in Q3 2022, closing a stake of 1,115 shares — an estimated $249K sold.

Walleye Trading first reported a position in OM in Q2 2022 and held it in 1 quarter. The position peaked at $249K in Q2 2022. 138 funds tracked by Wall St. Rank hold OM as of Q3 2022.

Walleye Trading reported no remaining Outset Medical position as of Q3 2022 after selling out during the quarter.
Walleye Trading sold 1,115 Outset Medical shares in Q3 2022, an estimated $249K.
Walleye Trading first reported a position in Outset Medical in Q2 2022 and held it in 1 quarter.
Walleye Trading's Outset Medical position peaked at $249K in Q2 2022.
138 funds tracked by Wall St. Rank held Outset Medical as of Q3 2022.

Based on Walleye Trading's 13F filing for Q3 2022, filed 14 Nov 2022.